As of March 31, 2010
| Corporate Name | MEDIPAL HOLDINGS CORPORATION | ||
| Head Office | 2-7-15, Yaesu, Chuo-ku, Tokyo 104-8461 Japan Phone: 81-3-3517-5800 |
||
| Founded | October 8, 1898 | ||
| Established | May 6, 1923 | ||
| Representative | Sadatake Kumakura, President and Chief Executive Officer | ||
| Paid-in Capital | 22,398 million yen | ||
| Shares Outstanding | 244,524,496 | ||
| Stock Listing | Tokyo Stock Exchange, First Section | ||
| Ticker Code | 7459 | ||
| Line of Business | As a pure holding company, MEDIPAL HOLDINGS controls, administers and supports the operating activities of companies in which it holds shares in the Prescription Pharmaceutical Wholesale Business, Cosmetics, Daily Necessities and OTC Pharmaceutical Wholesale Business, and Related Business, and conducts business development for the MEDIPAL Group. | ||
| Principal Shareholders | Takeda Pharmaceutical Company Limited, State Street Bank and Trust Company, Japan Trustee Services Bank, Ltd. (Trust Account), Employees Shareholders' Association of MP Group, Astellas Pharma Inc, Eisai Co., Ltd., Daiichi Sankyo Company, Limited, The Master Trust Bank of Japan, Ltd. (Trust Account), Kobayashi Pharmaceutical Co., Ltd., Sadatake Kumakura
|
||
| Employees | 11,363(consolidated) | ||
| Fiscal Year End | March 31 | ||
| Main Banks | Mizuho Bank, Ltd., Resona Bank, Limited, The Bank of Tokyo-Mitsubishi UFJ, Ltd., Sumitomo Mitsui Banking Corporation |
